CORRELATIONS BETWEEN PRO-INFLAMMATORY MARKERS AND GLYCATED HEMOGLOBIN IN TYPE 2 DIABETES PATIENTS
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 4
Abstract
Background and Aim. Markers of inflammation are predictive of diabetic macrovascular complications. In type 2 diabetes, inflammation might be responsible for enhancing insulin resistance and may contribute to the reduction of islet cells secretory function. In the present study, we investigated the correlation between the pro-inflammatory markers and glycated hemoglobin in patients with type 2 diabetes mellitus. Materials and Methods. 66 patients (32 women and 34 men) with type 2 diabetes were recruited for this study. On fasting plasma samples C-reactive protein, interleukin-6, tumor necrosis factor-α (TNF-α) and glycated hemoglobin (HbA1c) were assayed. C-reactive protein, interleukin-6 and TNF-α were measured using enzyme-linked immunosorbent assays. The HbA1c were measured using a high-performance liquid chromatography method. Results were compared to the corresponding parameters obtained for 38 subjects (18 women and 20 men) without type 2 diabetes (control group). Results. The groups were similar in terms of age and sex but there were statistically significant differences in the recorded parameters in diabetic patients compared to the control group. Circulating levels of C-reactive protein, interleukin-6, TNF-α and HbA1c were higher (p<0.05) in patients with type 2 diabetes mellitus compared to normally metabolic patients. In the patients with type 2 diabetes mellitus HbA1c were significantly correlated with circulating C-reactive protein (r=0.909, p<0.001) and interleukin-6 (r=0.883, p<0.001) levels. Conclusion. The markers of inflammation are significantly higher in patients with type 2 diabetes compared to subjects without diabetes. The elevated markers of inflammation (C-reactive protein and interleukin-6) were significantly correlated with glycemic control (HbA1c).
Authors and Affiliations
Rucsandra Dănciulescu Miulescu, Denisa Margina, Marlena Pascu, Sorin Paun
Keywords
Related Articles
- EP ID EP160854
- DOI -
- Views 113
- Downloads 0
SODIUM-GLUCOSE TRANSPORTER 2 INHIBITION – A POTENTIAL OPTION FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Glucose homeostasis is maintained by the balanced actions of glucose absorption, gluconeogenesis, glycogenolysis, glucose consumption, glucose excretion and glucose reabsorption. The human kidney is involved in glucose r...
THE DATABASE OF THE PATIENTS WITH DIABETES REGISTERED AT THE CLINICAL CENTER FOR DIABETES, NUTRITION AND METABOLIC DISEASES CLUJ
A database concerning the treatment and some demographical data requested by the National House of Health Insurance, of the more than 18000 patients attending the Diabetes Centre in Cluj is presented below, with its main...
Therapeutical Options For Optimizing The Glycemic Profile In A Patient With T2DM
Incretin-based therapies address some of the mechanisms of T2DM by improving β-cell function, inhibiting glucagon secretion, stimulating insulin secretion, reducing appetite and promoting weight loss. We present the case...
VITAMIN D DEFICIENCY EFFECTS UPON DIABETES MELLITUS AND ITS CARDIOVASCULAR AND RENAL CHRONIC COMPLICATIONS
Vitamin D was proved to have multiple non-skeletal actions, its receptor being expressed by almost every tissue, consequently proper levels being necessary for their optimal functioning. Although biologically inactive, 2...
CONSEQUENCES OF ADVANCES GLYCATION END PRODUCTS ACCUMULATION AND CLINICAL USEFULNESS OF THEIR ASSESSMENT USING A NON-INVASIVE TECHNIQUE
Accelerated formation and accumulation of advanced glycation end-products (AGEs) occur under circumstances of increased supply of substrates such as hyperglycaemic or oxidative stress and in age-related and chronic disea...